Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016, Article ID 2464791, 7 pages
http://dx.doi.org/10.1155/2016/2464791
Research Article

Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients

1Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA
2Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Seville, Spain
3Servicio de Medicina Interna, Hospital Quirón San Camilo, Madrid, Spain
4Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain

Received 22 June 2016; Accepted 18 August 2016

Academic Editor: Jörg D. Leuppi

Copyright © 2016 Maria L. Calero-Bernal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Bollée, C. Sarfati, G. Thiéry et al., “Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients,” Chest, vol. 132, no. 4, pp. 1305–1310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Pagano, L. Fianchi, L. Mele et al., “Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres,” British Journal of Haematology, vol. 117, no. 2, pp. 379–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. I. Martin and J. A. Fishman, “Pneumocystis pneumonia in solid organ transplantation,” American Journal of Transplantation, vol. 13, no. 4, pp. 272–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. M. Carmona and A. H. Limper, “Update on the diagnosis and treatment of Pneumocystis pneumonia,” Therapeutic Advances in Respiratory Disease, vol. 5, no. 1, pp. 41–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Enomoto, A. Azuma, A. Kohno et al., “Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection,” Respirology, vol. 15, no. 1, pp. 126–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Limper, K. P. Offord, T. F. Smith, and W. J. Martin II, “Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS,” American Review of Respiratory Disease, vol. 140, no. 5, pp. 1204–1209, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. D. P. Kofteridis, A. Valachis, M. Velegraki et al., “Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients,” Journal of Infection and Chemotherapy, vol. 20, no. 7, pp. 412–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. W. Wilson, A. H. Limper, T. E. Grys, T. Karre, N. L. Wengenack, and M. J. Binnicker, “Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity,” Diagnostic Microbiology and Infectious Disease, vol. 69, no. 2, pp. 145–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Maini, K. L. Henderson, E. A. Sheridan et al., “Increasing Pneumocystis pneumonia, England, UK, 2000–2010,” Emerging Infectious Diseases, vol. 19, no. 3, pp. 386–392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. A. Torres, R. F. Chemaly, R. Storey et al., “Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 25, no. 6, pp. 382–388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. H. Yale and A. H. Limper, “Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy,” Mayo Clinic Proceedings, vol. 71, no. 1, pp. 5–13, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. N. G. Mansharamani, R. Garland, D. Delaney, and H. Koziel, “Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states,” Chest, vol. 118, no. 3, pp. 704–711, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Festic, O. Gajic, A. H. Limper, and T. R. Aksamit, “Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features,” Chest, vol. 128, no. 2, pp. 573–579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Ko, B.-H. Jeong, H. Y. Park et al., “Outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients,” Journal of Critical Care, vol. 29, no. 3, pp. 356–361, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Briel, H. C. Bucher, R. Boscacci, and H. Furrer, “Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD006150, 2006. View at Google Scholar · View at Scopus
  16. J. G. Pareja, R. Garland, and H. Koziel, “Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia,” Chest, vol. 113, no. 5, pp. 1215–1224, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Delclaux, J.-R. Zahar, G. Amraoui et al., “Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients,” Clinical Infectious Diseases, vol. 29, no. 3, pp. 670–672, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Limper, K. S. Knox, G. A. Sarosi et al., “An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 1, pp. 96–128, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Martin-Garrido, E. M. Carmona, U. Specks, and A. H. Limper, “Pneumocystis pneumonia in patients treated with rituximab,” Chest, vol. 144, no. 1, pp. 258–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. F. Ali, C. B. Driscoll, P. R. Walters, A. H. Limper, and E. M. Carmona, “β-glucan-activated human b lymphocytes participate in innate immune responses by releasing proinflammatory cytokines and stimulating neutrophil chemotaxis,” Journal of Immunology, vol. 195, no. 11, pp. 5318–5326, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. F. E. Lund, M. Hollifield, K. Schuer, J. L. Lines, T. D. Randall, and B. A. Garvy, “B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection,” Journal of Immunology, vol. 176, no. 10, pp. 6147–6154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. F. E. Lund, K. Schuer, M. Hollifield, T. D. Randall, and B. A. Garvy, “Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P. carinii-specific antibody,” Journal of Immunology, vol. 171, no. 3, pp. 1423–1430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. R. R. Rapaka, D. M. Ricks, J. F. Alcorn et al., “Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina,” Journal of Experimental Medicine, vol. 207, no. 13, pp. 2907–2919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. U. M. Overgaard and J. Helweg-Larsen, “Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002–2004,” Scandinavian Journal of Infectious Diseases, vol. 39, no. 6-7, pp. 589–595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Suryaprasad and J. H. Stone, “When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases,” Arthritis Care and Research, vol. 59, no. 7, pp. 1034–1039, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Fillatre, O. Decaux, S. Jouneau et al., “Incidence of pneumocystis Jiroveci pneumonia among groups at risk in HIV-negative patients,” American Journal of Medicine, vol. 127, no. 12, pp. 1242–1242.e17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Hardak, A. Neuberger, M. Yigla et al., “Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection,” Respirology, vol. 17, no. 4, pp. 681–686, 2012. View at Publisher · View at Google Scholar · View at Scopus